CN104474404A - 一种防治免疫缺陷患者感染的复方栓剂 - Google Patents
一种防治免疫缺陷患者感染的复方栓剂 Download PDFInfo
- Publication number
- CN104474404A CN104474404A CN201410816003.2A CN201410816003A CN104474404A CN 104474404 A CN104474404 A CN 104474404A CN 201410816003 A CN201410816003 A CN 201410816003A CN 104474404 A CN104474404 A CN 104474404A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- vitamin
- flos
- drugs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 19
- 206010061598 Immunodeficiency Diseases 0.000 title abstract description 5
- 208000029462 Immunodeficiency disease Diseases 0.000 title abstract description 5
- 230000007813 immunodeficiency Effects 0.000 title abstract description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 25
- 239000000829 suppository Substances 0.000 claims abstract description 25
- 229940038481 bee pollen Drugs 0.000 claims abstract description 20
- 229940088594 vitamin Drugs 0.000 claims abstract description 20
- 229930003231 vitamin Natural products 0.000 claims abstract description 20
- 235000013343 vitamin Nutrition 0.000 claims abstract description 20
- 239000011782 vitamin Substances 0.000 claims abstract description 20
- 241001116389 Aloe Species 0.000 claims abstract description 18
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 18
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 18
- 235000011399 aloe vera Nutrition 0.000 claims abstract description 18
- 235000008434 ginseng Nutrition 0.000 claims abstract description 18
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 18
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 17
- 239000004863 Frankincense Substances 0.000 claims abstract description 17
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 16
- 241000628997 Flos Species 0.000 claims description 61
- 210000000582 semen Anatomy 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 23
- 240000005819 Magnolia denudata Species 0.000 claims description 18
- 235000016094 Magnolia denudata Nutrition 0.000 claims description 18
- 229940124530 sulfonamide Drugs 0.000 claims description 18
- 241000208340 Araliaceae Species 0.000 claims description 17
- 239000013078 crystal Substances 0.000 claims description 17
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 claims description 17
- 241000717739 Boswellia sacra Species 0.000 claims description 16
- 241001057584 Myrrha Species 0.000 claims description 16
- 241000131808 Scolopendra Species 0.000 claims description 16
- 230000002950 deficient Effects 0.000 claims description 15
- 238000002360 preparation method Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 4
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 239000013521 mastic Substances 0.000 claims description 3
- 238000000465 moulding Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical group OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 43
- 239000003814 drug Substances 0.000 abstract description 41
- 230000006870 function Effects 0.000 abstract description 32
- 229940079593 drug Drugs 0.000 abstract description 21
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 16
- 201000010099 disease Diseases 0.000 abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 11
- 238000012360 testing method Methods 0.000 abstract description 11
- 206010061218 Inflammation Diseases 0.000 abstract description 10
- 230000002401 inhibitory effect Effects 0.000 abstract description 8
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 210000000987 immune system Anatomy 0.000 abstract description 5
- 230000004054 inflammatory process Effects 0.000 abstract description 5
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 102000003914 Cholinesterases Human genes 0.000 abstract description 3
- 108090000322 Cholinesterases Proteins 0.000 abstract description 3
- 230000002924 anti-infective effect Effects 0.000 abstract description 3
- 229940048961 cholinesterase Drugs 0.000 abstract description 3
- 210000000265 leukocyte Anatomy 0.000 abstract description 3
- 230000002155 anti-virotic effect Effects 0.000 abstract description 2
- 238000005728 strengthening Methods 0.000 abstract description 2
- 238000012795 verification Methods 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 244000003416 Asparagus officinalis Species 0.000 abstract 1
- 235000005340 Asparagus officinalis Nutrition 0.000 abstract 1
- 241000559235 Bolboschoenus fluviatilis Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 241000258920 Chilopoda Species 0.000 abstract 1
- 244000045195 Cicer arietinum Species 0.000 abstract 1
- 235000010523 Cicer arietinum Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 241000737253 Lygodium japonicum Species 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 206010057249 Phagocytosis Diseases 0.000 abstract 1
- 241001499733 Plantago asiatica Species 0.000 abstract 1
- 240000003705 Senecio vulgaris Species 0.000 abstract 1
- 241000992149 Solidago decurrens Species 0.000 abstract 1
- 241000830536 Tripterygium wilfordii Species 0.000 abstract 1
- 230000003260 anti-sepsis Effects 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- 230000009194 climbing Effects 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- HTUMBQDCCIXGCV-UHFFFAOYSA-N lead oxide Chemical compound [O-2].[Pb+2] HTUMBQDCCIXGCV-UHFFFAOYSA-N 0.000 abstract 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 abstract 1
- 235000019477 peppermint oil Nutrition 0.000 abstract 1
- 230000008782 phagocytosis Effects 0.000 abstract 1
- 235000015398 thunder god vine Nutrition 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 28
- 239000008280 blood Substances 0.000 description 28
- 210000004185 liver Anatomy 0.000 description 23
- 239000000796 flavoring agent Substances 0.000 description 19
- 235000019634 flavors Nutrition 0.000 description 19
- 231100000614 poison Toxicity 0.000 description 17
- 238000011282 treatment Methods 0.000 description 14
- 208000002193 Pain Diseases 0.000 description 12
- 239000003440 toxic substance Substances 0.000 description 11
- 235000019156 vitamin B Nutrition 0.000 description 11
- 239000011720 vitamin B Substances 0.000 description 11
- 229930003270 Vitamin B Natural products 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 9
- 208000004880 Polyuria Diseases 0.000 description 8
- 230000035619 diuresis Effects 0.000 description 8
- 210000004072 lung Anatomy 0.000 description 8
- 210000002784 stomach Anatomy 0.000 description 8
- 230000008961 swelling Effects 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 230000003110 anti-inflammatory effect Effects 0.000 description 7
- 235000009508 confectionery Nutrition 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 230000036039 immunity Effects 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 6
- 241000191967 Staphylococcus aureus Species 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 208000026435 phlegm Diseases 0.000 description 6
- 239000002574 poison Substances 0.000 description 6
- 231100000419 toxicity Toxicity 0.000 description 6
- 230000001988 toxicity Effects 0.000 description 6
- 201000004624 Dermatitis Diseases 0.000 description 5
- 206010017533 Fungal infection Diseases 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 208000031888 Mycoses Diseases 0.000 description 5
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 5
- 208000002474 Tinea Diseases 0.000 description 5
- 241000130764 Tinea Species 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 230000002147 killing effect Effects 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 231100000252 nontoxic Toxicity 0.000 description 5
- 230000003000 nontoxic effect Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 208000002874 Acne Vulgaris Diseases 0.000 description 4
- 206010010904 Convulsion Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 102000002322 Egg Proteins Human genes 0.000 description 4
- 108010000912 Egg Proteins Proteins 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 4
- 206010035664 Pneumonia Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 206010000496 acne Diseases 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 206010006451 bronchitis Diseases 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 235000013345 egg yolk Nutrition 0.000 description 4
- 210000002969 egg yolk Anatomy 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 244000045947 parasite Species 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000000144 pharmacologic effect Effects 0.000 description 4
- 230000001047 pyretic effect Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 231100000331 toxic Toxicity 0.000 description 4
- 230000002588 toxic effect Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 3
- 241001489138 Haliotis diversicolor Species 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000001754 anti-pyretic effect Effects 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 239000002221 antipyretic Substances 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229960002685 biotin Drugs 0.000 description 3
- 235000020958 biotin Nutrition 0.000 description 3
- 239000011616 biotin Substances 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- -1 lipid peroxide Chemical class 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 208000008742 seborrheic dermatitis Diseases 0.000 description 3
- 230000036559 skin health Effects 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 3
- MFIHSKBTNZNJIK-RZTYQLBFSA-N (3s,3ar,6s,6ar)-3-(3,4-dimethoxyphenyl)-6-(3,4,5-trimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furan Chemical compound C1=C(OC)C(OC)=CC=C1[C@@H]1[C@@H](CO[C@@H]2C=3C=C(OC)C(OC)=C(OC)C=3)[C@@H]2CO1 MFIHSKBTNZNJIK-RZTYQLBFSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241001480043 Arthrodermataceae Species 0.000 description 2
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 2
- 208000004429 Bacillary Dysentery Diseases 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 206010008342 Cervix carcinoma Diseases 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 2
- 241000725303 Human immunodeficiency virus Species 0.000 description 2
- 208000015817 Infant Nutrition disease Diseases 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 206010033128 Ovarian cancer Diseases 0.000 description 2
- 206010061535 Ovarian neoplasm Diseases 0.000 description 2
- 240000005001 Paeonia suffruticosa Species 0.000 description 2
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 235000014676 Phragmites communis Nutrition 0.000 description 2
- 206010057190 Respiratory tract infections Diseases 0.000 description 2
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 2
- 241000282894 Sus scrofa domesticus Species 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 2
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 2
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 2
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 2
- 206010046914 Vaginal infection Diseases 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 206010047623 Vitamin C deficiency Diseases 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 231100000360 alopecia Toxicity 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 238000012742 biochemical analysis Methods 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 201000010881 cervical cancer Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 230000037304 dermatophytes Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 235000019688 fish Nutrition 0.000 description 2
- 206010016766 flatulence Diseases 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 210000003494 hepatocyte Anatomy 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 238000003305 oral gavage Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 208000010233 scurvy Diseases 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 201000005113 shigellosis Diseases 0.000 description 2
- 210000002460 smooth muscle Anatomy 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 230000000451 tissue damage Effects 0.000 description 2
- 231100000827 tissue damage Toxicity 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- YLRXAIKMLINXQY-ZDUSSCGKSA-O (S)-magnoflorine Chemical compound C1=C(OC)C(O)=C2C3=C(O)C(OC)=CC=C3C[C@@H]3[N+](C)(C)CCC1=C23 YLRXAIKMLINXQY-ZDUSSCGKSA-O 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003671 Atrioventricular Block Diseases 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000238008 Cerithidea rhizophorarum Species 0.000 description 1
- 208000013017 Child Nutrition disease Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 241000005787 Cistanche Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 241000903946 Clematidis Species 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- 244000086443 Craterellus fallax Species 0.000 description 1
- 235000007926 Craterellus fallax Nutrition 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 229930191978 Gibberellin Natural products 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 208000032923 Lobar pneumonia Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- KYEAXNAYHSCLMT-CVVGWEDFSA-N Magnoflorine Natural products C[C@H]1OC=C2[C@@H]3[C@@H]1CN4CCc5c([nH]c6ccccc56)[C@@H]4[C@@H]3OC2=O KYEAXNAYHSCLMT-CVVGWEDFSA-N 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 208000034762 Meningococcal Infections Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 231100000757 Microbial toxin Toxicity 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 206010029803 Nosocomial infection Diseases 0.000 description 1
- 208000010195 Onychomycosis Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000016816 Pisum sativum subsp sativum Nutrition 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241001113283 Respirovirus Species 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000607760 Shigella sonnei Species 0.000 description 1
- 206010040639 Sick sinus syndrome Diseases 0.000 description 1
- 208000001203 Smallpox Diseases 0.000 description 1
- 206010041303 Solar dermatitis Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 108010017842 Telomerase Proteins 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 102000007501 Thymosin Human genes 0.000 description 1
- 108010046075 Thymosin Proteins 0.000 description 1
- 101710183280 Topoisomerase Proteins 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 102000044209 Tumor Suppressor Genes Human genes 0.000 description 1
- 108700025716 Tumor Suppressor Genes Proteins 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 241000870995 Variola Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000012873 acute gastroenteritis Diseases 0.000 description 1
- 231100000570 acute poisoning Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000001716 anti-fugal effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001826 anti-prostatic effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 239000009670 cang er zi wan Substances 0.000 description 1
- 210000001043 capillary endothelial cell Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- VZGDMQKNWNREIO-UHFFFAOYSA-N carbon tetrachloride Substances ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 1
- 230000002026 carminative effect Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000004098 cellular respiration Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 235000005489 dwarf bean Nutrition 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000008029 eradication Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 239000003448 gibberellin Substances 0.000 description 1
- IXORZMNAPKEEDV-OBDJNFEBSA-N gibberellin A3 Chemical class C([C@@]1(O)C(=C)C[C@@]2(C1)[C@H]1C(O)=O)C[C@H]2[C@]2(C=C[C@@H]3O)[C@H]1[C@]3(C)C(=O)O2 IXORZMNAPKEEDV-OBDJNFEBSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 210000001320 hippocampus Anatomy 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 231100000003 human carcinogen Toxicity 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 description 1
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- MFIHSKBTNZNJIK-UHFFFAOYSA-N medioresinol dimethyl ether Natural products C1=C(OC)C(OC)=CC=C1C1C(COC2C=3C=C(OC)C(OC)=C(OC)C=3)C2CO1 MFIHSKBTNZNJIK-UHFFFAOYSA-N 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 230000004995 multiple fission Effects 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000007991 neuronal integrity Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 229960002969 oleic acid Drugs 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000001995 reticulocyte Anatomy 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 210000001625 seminal vesicle Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- LCJVIYPJPCBWKS-NXPQJCNCSA-N thymosin Chemical compound SC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CO)C(=O)N[C@H](CO)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(O)=O)C(O)=O LCJVIYPJPCBWKS-NXPQJCNCSA-N 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 201000005882 tinea unguium Diseases 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000001457 vasomotor Effects 0.000 description 1
- 201000010653 vesiculitis Diseases 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/68—Plantaginaceae (Plantain Family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
- A61K36/855—Clerodendrum, e.g. glorybower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种防治免疫缺陷患者感染的复方栓剂,通过临床试验反复验证配置而成的,符合传统中医学的理论。以人参花、金银花、回回豆、芦笋、芦荟、无花果、蜂花粉抑菌、抗病毒、抗炎、补充人体元气、增强免疫系统功能为君药,以密陀僧、蜈蚣、雷公藤、千里光、没药、车前、石决明、藿香败毒散结、活血通络、抗感染、抗病原微生物作用为臣药,以维生素c改进白细胞的吞噬功能,维生素b可抑制胆碱酯酶活性,减轻炎症反应,结晶磺胺抗菌消炎,海金沙、玉兰花、大青叶、牡丹花为佐药加强君药和臣药的治疗功能,以乳香、一枝黄花、淫羊藿、三棱、冰片、薄荷油为使药指引导诸药直达病所。
Description
技术领域
本发明涉及中药领域,具体的说是一种防治免疫缺陷患者感染的复方栓剂。
背景技术
免疫缺陷病人的真菌感染存在高发病率和高死亡率,发生这类感染危险最大的是因癌症化疗、骨髓或器官移植、高剂量皮质激素使用个AIDS导致免疫系统严重受损的病人,随着进行骨髓和实体器官移植、以及接受更具攻击性化疗的病人增多,有高严重真菌感染的病人数亦在不断增多。
据报道,真菌感染发生率占院内感染菌群分布的第四位,且近年来有明显增加趋势。重症监护室患者不仅基础状态较差,而且经常要接受光谱抗生素的长期治疗以及多种创伤性操作的诊疗,导致免疫功能受损,一旦发生真菌感染,其住院时间和病死率增加。
栓剂指药物与适宜基质制成的具有一定形状的供人体腔道内给药的固体制剂。栓剂在常温下为固体,塞入腔道后,在体温下能迅速软化熔融或溶解于分泌液,逐渐释放药物而产生局部或全身作用。栓剂可通过直肠吸收药物发挥全身作用,并可避免肝脏的首过效应。
因此免疫缺陷者出现发热时应先考虑感染的可能,一方面进行病原学检查,一方面应争取时间抗感染治疗。对患者的各种免疫缺陷状态也应作出适当处理。对免疫缺陷者感染的治疗措施基本与一般感染相同,但选用的抗菌药物应具备下列条件:①为杀菌剂。②对病原体有高度活性。③在感染部位可达有效浓度。④对细胞内微生物有作用。⑤不易导致耐药株的出现。⑤毒性低。⑦可由需要途径给药。
发明内容
本发明的目的是提供一种应用于治疗免疫缺陷患者中进行性的、可能威胁生命的感染、抑制细胞中人免疫缺陷病毒的复制,具体地说是一种防治免疫缺陷患者感染的复方栓剂。
一种防治免疫缺陷患者感染的复方栓剂,通过临床试验反复验证配置而成的,符合传统中医学的理论。以人参花、金银花、回回豆、芦笋、芦荟、无花果、蜂花粉抑菌、抗病毒、抗炎、补充人体元气、增强免疫系统功能为君药,以密陀僧、蜈蚣、雷公藤、千里光、没药、车前、石决明、藿香败毒散结、活血通络、抗感染、抗病原微生物作用为臣药,以维生素c改进白细胞的吞噬功能,维生素b可抑制胆碱酯酶活性,减轻炎症反应,结晶磺胺抗菌消炎,海金沙、玉兰花、大青叶、牡丹花为佐药加强君药和臣药的治疗功能,以乳香、一枝黄花、淫羊藿、三棱、冰片、薄荷油为使药指引导诸药直达病所。
作为优选,所述维生素c为片剂。
作为优选,所述维生素b为片剂。
一种防治免疫缺陷患者感染的复方栓剂,其特征在于,是由以下重量份的原料组成:
人参花20-30份、金银花20-30份、回回豆0.1-1.0份、芦笋20-30份、芦荟20-30份、无花果20-30份、蜂花粉20-30份、密陀僧10-20份、蜈蚣10-20份、雷公藤10-20份、千里光10-20份、没药10-20份、车前10-20份、石决明10-20份、藿香10-20份、维生素c1-10份、维生素b1-10份、结晶磺胺1-10份、海金沙1-10份、玉兰花1-10份、大青叶1-10份、牡丹花1-10份、乳香0.1-1.0份、一枝黄花0.1-1.0份、淫羊藿0.1-1.0份、三棱0.1-1.0份、冰片5-15份、薄荷油20-30份。
制备方法:
1)按配方比例将人参花、金银花、玉兰花、牡丹花、蜈蚣烘干粉碎至100-200目细粉备用;
①按配方比例将回回豆、芦笋、芦荟、无花果、密陀僧、雷公藤、千里光、没药、车前、石决明、藿香、海金沙、大青叶、乳香、一枝黄花、淫羊藿、三棱除杂质,去腐败物,加水浸泡30分钟,后加入五倍量的水煎煮1小时,煮提二次煎液,过滤、浓缩滤液至密度1.0-1.45(70-80℃)的膏体,在70℃干燥,粉碎至100-200目细粉备用;
②按配方比例将蜂花粉、维生素c片、维生素b片、结晶磺胺、冰片粉碎至100-200目细粉备用;
③按配方比例将三次备用细粉加入薄荷油搅拌均匀,浇模冷却,制成栓剂。
用法用量:每盒7枚,每枚含200mg。每晚1枚,连续使用7天为一完整疗程。
一种防治免疫缺陷患者感染的复方栓剂,其特征在于,是由以下重量份的原料组成:
人参花22-28份、金银花22-28份、回回豆0.2-0.8份、芦笋22-28份、芦荟22-28份、无花果22-28份、蜂花粉22-28份、密陀僧12-18份、蜈蚣12-18份、雷公藤12-18份、千里光12-18份、没药12-18份、车前12-18份、石决明12-18份、藿香12-18份、维生素c2-8份、维生素b2-8份、结晶磺胺2-8份、海金沙2-8份、玉兰花2-8份、大青叶2-8份、牡丹花2-8份、乳香0.2-0.8份、一枝黄花0.2-0.8份、淫羊藿0.2-0.8份、三棱0.2-0.8份、冰片6-14份、薄荷油22-28份。
一种防治免疫缺陷患者感染的复方栓剂,其特征在于,是由以下重量份的原料组成:
人参花25份、金银花25份、回回豆0.5份、芦笋25份、芦荟25份、无花果25份、蜂花粉25份、密陀僧15份、蜈蚣15份、雷公藤15份、千里光15份、没药15份、车前15份、石决明15份、藿香15份、维生素c5份、维生素b5份、结晶磺胺5份、海金沙5份、玉兰花5份、大青叶5份、牡丹花5份、乳香0.5份、一枝黄花0.5份、淫羊藿0.5份、三棱0.5份、冰片10份、薄荷油25份。
本发明涉及中药的药理及药性:
人参花:
【性味】:苦味回甜,有人参的辛甜味。
【功用】:补充人体元气,恢复体力,增强人体免疫力。
金银花:
【性味】性甘、寒;
【功用】有清热、解毒、消炎、抗菌之作用。《本草纲目》载“金银花,善于化毒,故治痈疽、肿毒、疮癣……”。自古以来,金银花常用于清热解毒,治疗温病发热,热毒血痢,痈疡等症,亦用于风热感冒,支气管炎等病症。现代药理研究表明,金银花具有抑菌、抗病毒、抗炎、解热、调节免疫等作用。
清热散毒,《本草纲目》载“金银花,善于化毒,故治痈疽、肿毒、疮癣……”。自古以来,金银花常用于清热解毒,治疗温病发热,热毒血痢,痈疡等症。现代药理研究表明,金银花具有抑菌、抗病毒、抗炎、解热、调节免疫等作用中医认为,金银花性寒、味甘、气平,具有清热解毒之功效,可以治疗热毒肿疡、痈疽疔疮等症。且兼有宣散作用。金银花清热解毒作用颇强。金银花能延缓呼吸道病毒对细胞的病变作用,是清热解毒的代表药物,热毒实质除含多种致病微生物外,微生物毒素也占重要位置。金银花制剂腹腔注射能明显降低绿脓杆菌的内毒素所致家兔的白细胞数下降,白细胞左移现象等有明显对抗作用。金银花配伍黄芩制备成制剂可明显减轻绿脓杆菌内毒素所致兔的中毒症状及死亡。
回回豆:
和中下气,利小便,解疮毒。治霍乱转筋,脚气,痈肿。
①《绍兴校定证类本草》:主调颗营卫,益中平气。
②《日用本草》:煮食下乳汁。
③《纲目》:研末涂痈肿、痘疮。
④《本草从新》:理脾胃。
⑤《医林纂要》:利小便。
⑥《随息居饮食谱》:煮食,和中生津,止渴下气,通乳消胀。
营养分析:在回回豆荚和豆苗的嫩叶中富含维生素C和能分解体内亚硝胺的酶,可以分解亚硝胺,具有抗癌防癌的作 用。回回豆与一般蔬菜有所不同,所含的止杈酸、赤霉素和植物凝素等物质,具有抗菌消炎,增强新陈代谢的功能。在荷兰豆和豆苗中含有较为丰富的膳食纤维,可以防止便秘,有清肠作用。⒈增强机体免疫功能:回回豆中富含人体所需的各种营养物质,尤其是含有优质蛋白质,可以提高机体的抗病能力和康复能力。⒉防癌治癌:回回豆中富含胡萝卜素,食用后可防止人体致癌物质的合成,从而减少癌细胞的形成,降低人体癌症的发病率。⒊通利大肠:回回豆中富含粗纤维,能促进大肠蠕动,保持大便能畅,起到清洁大肠的作用。
芦笋:
【药理价值】1、有助于平抑血压降血脂;2、有助于抑制心脏血管疾病;3、有助于预防和抗癌;4、有助于防治老年便秘、利尿解乏;5、有助于抑制和抵抗病毒菌;6、有助于增强体质消除疲劳。
【营养价值】1、高维生素、高纤维素、高蛋白2、低糖、低脂肪3、含有多种人体必需的大量元素和微量元素
【保健功效】1、防癌抗癌功效,能抑制拓扑异构酶活性,直接杀灭癌细胞,破坏癌细胞端粒酶,使癌细胞不能增殖分裂而凋之,激活抗癌基因调控信号,传导细胞生长正常化。2、对心脏血管疾病的治疗作用,芦笋能抑制高血压,防止血管硬化,降低血脂及胆固醇。3、对人体免疫系统的影响,芦笋可降低循环免疫复合物CIC含量,可产生胸腺素,促进T细胞的产生,从而提高免疫功能,调节免疫机制。4、在抗衰老方面的作用能够降低人体器官的过氧化脂质,LOP的含量,提高超氧化物歧化酶SOD的活性从而延缓衰老。
芦荟:《中华人民共和国药典》(2000年版一部)如是说性味与归经:苦,寒;归肝、胃、大肠经;功能与主治:清肝热,通便;用于便秘,小儿疳积,惊风;外治湿癣。《本草纲目》如是说性味:苦,寒,无毒;主治:热风烦闷,胸隔间热气,明目镇心,小儿癫痫惊风,疗五疳,杀三虫及痔病疮瘘,解巴豆毒。《中华本草》如是说集中草药之大成的《中华本草》将芦荟的保健功能概括为:⑴泄下,即润肠通便;⑵调节人体免疫力;⑶抗肿廇;⑷保护肝脏;⑸抗胃损伤;⑹抗菌;⑺修复组织损伤;⑻对皮肤的保护作用。苦,寒。归肝、胃、大肠经。功能与主治:泄下,即润肠通便;调节人体免疫力;抗肿廇;保护肝脏;抗胃损伤;抗菌;修复组织损伤;对皮肤的保护作用。
无花果:
【性味】味甘、平;
【功用】润肺止咳,清热润肠:用于咳喘,咽喉肿痛,便秘,痔疮。
蜂花粉:抗前列腺增生、抗炎抗缺氧、增强免疫调节、抗衰老、降血脂及美容养颜等。①增强人体综合免疫功能:蜂花粉多糖能激活巨噬细胞的吞噬活动,提高人体抗病能力。②防衰老、美容作用:蜂花粉属营养性的美容化妆品,花粉中的VE、超氧化歧化酶(SOD)、硒等成分能滋润营养肌肤,恢复皮肤的弹性和光洁。花粉中的肌醇可使白发变黑,脱发渐生,保持头发乌黑亮丽。③防治脑心血管疾病:花粉中的黄酮类化合物能有效清除血管壁上脂肪的沉积,从而起软化血管和降血脂的作用。④防治前列腺疾病:花粉是前列腺炎的克星,以油菜花粉、荞麦花粉效果最佳。我国治前列腺疾病的有效药物-前列康就是以花粉为原料的。 ⑤减肥:服用蜂花粉可以吸收足够的营养,造成饱食感。同时,花粉中的卵磷脂可燃烧过剩的脂肪,达到减肥的目的。⑥调节肠胃功能:花粉有许多杀菌成分,能杀灭大肠杆菌等,并能防治便秘。⑦保肝护肝:花粉中的黄酮类化合物同样可防止脂肪在肝上的沉积。⑧调节神经系统,促进睡眠。⑨辅助治疗其他疾病:花粉对贫血、糖尿病、改善记忆力、更年期障碍等有较好效果。⑩辅助治疗前列腺疾病:可调节男性内分泌,恢复膀胱尿道平滑肌功能。
密陀僧:
【性味归经】性咸、辛、平;入肝、脾经。
【功效】消肿、杀虫、收敛防腐、坠痰镇惊、经试验对多种致病皮肤真菌,有不同程度的抑制作用,能收缩粘膜及溃疡处的血管,使分泌减少,并有消炎的防止感染等作用。
蜈蚣:
【性味归经】味辛,温;归肝经。
【功能主治】息风镇痉,功毒散结,通络止痛。用于小儿惊风,抽搐痉挛,中风口歪,半身不遂,破伤风,风湿顽痹,疮疡,瘰疬,毒蛇咬伤。
雷公藤:
【药性】 苦、辛,凉。归肝、脾、肺经。
【功用】祛风,解毒,杀虫。外用治风湿性关节炎,皮肤发痒,杀蛆虫、孑孓,灭钉螺,毒鼠。[药效] 祛风除湿,活血通络,消肿止痛,杀虫解毒。(1)败毒抗癌,用于癌瘤积毒(2)祛湿散结,用于湿热结节。
千里光:
【性味归经】苦,甘,寒,辛,凉。无毒。
【功能主治】清热解毒、杀虫、明目。现代药理研究:1、抗菌作用,对志贺氏痢疾杆菌、金黄色葡萄球菌、腊样炭疽杆菌有较强的抗菌作用。2、抗螺旋体作用。3、抑制阴道滴虫作用。《中药大辞典》报道用于治疗:各种炎症性疾病疥癞疮毒、湿疹、阴道滴虫、各型阴道炎、宫颈炎、痈疽、痔疮等。
没药:
【性味】苦,辛,平。
【功用】抗菌、抗微生物、抗炎、收敛、具香胶特质、除臭、祛肠胃胀气、消毒、利尿、通经、化痰、杀霉菌、激励、利胃、催汗、补身、利子宫、治创伤,对成熟\干裂\脱粗糙皮肤有助益。
车前:
【性味】甘;淡;性微寒;归经:归肺;肝;肾;膀胱经。
【功能主治】清热利尿;渗湿止泻;明目;祛痰。主小便不利;淋浊带下;水肿胀满;暑湿泻痢;目赤障翳;痰热咳喘。抗病原微生物作用:在试管内,车前水浸剂对同心性毛癣菌、许兰黄癣菌、奥杜盎小芽胞癣菌、铁锈色小芽胞癣菌、羊毛状小芽胞癣菌、星形奴卡菌等皮肤真菌有不同程度的抑制作用。亦有报告指出,对多种致病菌,如金黄色葡萄球菌、宋内痢疾杆菌、大肠杆菌、绿脓杆菌及伤寒杆菌亦有不同程度的抑制作用。车前醇提取物(15mg/ml)对钩端螺旋体有杀灭作用。
石决明:
【性味】咸、平、无毒。
【主治】1.畏光。用石决明、黄菊花、甘草各一钱,水煎,冷后服。2.痘后目翳。用石决明火煅过,研为末,加谷精草等分,共研细,可烤猪肝蘸吃。3.肝虚目翳(气虚、血虚、肝虚,眼睛充血,夜如鸡啄,生出浮翳)。用石决明(烧成灰)、木贼(焙),等分为末。每取二钱,与姜、枣同用水煎,连渣服下。每天服三次。4.青盲、雀目。用石决明一两(烧存性)、加苍术三两(去皮),共研为末。每取三钱,放入切开的猪肝中,扎定,加水煎熟,乘热熏目,待转温后,食肝饮汁。5.小便淋症。用石决明去粗皮,研为末,水飞过。每服二钱,熟水送下。一天服二次。如淋中有软硬物,即加朽木末五分。
【药理作用】1.有清热、镇静、降血压、拟交感神经的作用。2.抗感染作用:九孔鲍提取液的抗菌实验(杯碟法)表明,对金黄葡萄球菌、大肠杆菌、绿脓杆菌的抑菌效力最强。其贝壳内层水解液经小白鼠抗四氯化碳急性中毒(肝炎模型)实验表明,给药组谷丙转氨酶较对照组明显下降。病理切片观察对照组肝细胞有明显坏死灶,而给药组肝细胞几无变性。羊鲍鱼汁,于体外有抗有金黄色化脓葡萄球菌(Staphylococcusaureus)、抗流行性感冒病毒的作用。3.其它作用:九孔鲍酸性提取液对家兔体外,体内凝血时间的影响实验表明,均具有显著的抗凝作用(P<0.001)。其贝壳提取液对小白鼠常压下缺氨实验表明有明显耐氧作用;还可使离体小鼠肺的灌流量增加,扩张气管、支气管的平滑肌(扩张率17%)。通过灌胃及腹腔两种途径,连续给小白鼠九孔鲍水煎醇沉淀提取液一周后,测定脾脏特异玫瑰花结数目表明,具有免疫抑制作用(P<0.001)。
藿香:辛,微温。归脾、胃、肺经。 功能主治:芳香化浊,开胃止呕,发表解暑。用于湿浊中阻,脘痞呕吐,暑湿倦怠,胸闷不舒,寒湿闭暑,腹痛吐泻,鼻渊头痛。 “藿香,清芬微温,善理中州湿浊痰涎,为醒脾快胃,振动清阳妙品。《别录》治风水毒肿者,祛除湿浊,自能清理水道也。1. 抗真菌作用 2. 抗钩端螺旋体作用3. 抗病毒作用 4. 对消化系统的作用。
维生素C:
显示抗坏血酸生物活性的化合物的通称,是一种水溶性维生素,水果和蔬菜中含量丰富。在氧化还原代谢反应中起调节作用,缺乏它可引起坏血病。维生素C在体内参与多种反应,如参与氧化还原过程,在生物氧化和还原作用以及细胞呼吸中起重要作用。从组织水平看,维生素C的主要作用是与细胞间质的合成有关。包括胶原,牙和骨的基质,以及毛细血管内皮细胞间的接合物。因此,当维生素C缺乏所引起的坏血病时,伴有胶原合成缺陷,表现为创伤难以愈合,牙齿形成障碍和毛细血管破损引起大量瘀血点,瘀血点融合形成瘀斑。
维生素B:
维生素B(Vitamin B)也作维他命B,是某些维生素的总称,它们常常来自于相同的食物来源,如酵母等。维生素B曾经被认为是像维生素C那样具有单一结构的有机化合物,但是后来的研究证明它其实是一组有着不同结构的化合物,于是它的成员有了独立的名称,如维生素B1,而维生素B成为了一个总称,有的时候也被称为维生素B族、维生素B杂或维生素B复合群。维生素B都是水溶性维生素,它们是协同作用,调节新陈代谢,维持皮肤和肌肉的健康,增进免疫系统和神经系统的功能,促进细胞生长和分裂(包括促进红血球的产生,预防贫血发生)。
与护肤密切相关的B族维生素包括B1.B2.B3.B5.B6和H等。维生素B1又称硫胺素,可抑制胆碱酯酶活性,减轻皮肤炎症反应,有防治脂溢性皮炎、湿疹、增进皮肤健康之功效。主要来源于谷物、鲜蔬菜、水果、牛乳、蛋黄、瘦肉、肝、酵母、糠麸、花生等。维生素B2又称核黄素,参与细胞的氧化还原反应,血红蛋白的合成及糖、蛋白质、脂肪的代谢,能帮助皮肤抵抗日光的损害,促进细胞再生。体内缺乏维生素B2时,皮肤对日光比较敏感,容易出现日光性皮炎,被日光晒久了,脸部发红发痒,在鼻子周围有粉状物出现。主要来源于蛋黄、牛乳、酵母、绿叶蔬菜、米糠、胚芽、动物肝脏与肾脏、胡萝卜、酿造酵母、鱼、橘子、柑、橙等。维生素B3又称为烟酸,可以抑制皮肤黑色素的形成,防止皮肤粗糙。有利于受伤害的细胞或皮肤复原。对维持正常组织,尤其是皮肤、消化道、神经系统的完整性具有重要作用。维生素B6与皮肤健康有密切关系,是很多酶和辅助酶分子结构的一部分。促进氨基酸的代谢以保持皮肤健康,可降低毛细血管壁通透性及透明质酸酶活性,降低变态反应、炎症反应,促进上皮细胞生长。可用于防治皮肤粗糙、粉刺、日光晒伤、止痒和阳光晒黑,也可用于防治脂溢性皮肤炎症、一般性痤疮、干性脂溢性皮炎湿疹和落屑性皮肤变化。主要来源于肝、蛋黄、谷物、胚芽、豆类、牛乳、鱼类、肉类、蔬菜。维生素H又称生物素(biotin),能促进皮肤新陈代谢,改善皮肤粗糙,防止毛发脱落、脂溢性皮炎、多晶型的粉刺(痤疮)等。存在于肝、蛋黄、奶、酵母等食物中。
结晶磺胺:
【性 状】白色结晶颗粒或粉末;无臭,味初苦后微甜;光照下色渐变暗;极易溶于沸水,易溶于丙酮,略溶于乙醇,微溶于水,能溶于稀盐酸或氢氧化碱溶液;熔点:164.5℃-166.5℃。
【适 应 症】磺胺类抗菌消炎药,用于溶血性链球菌、脑膜炎球菌的感染;对磺胺过敏者、严重肝肾患者忌用;外用。
海金沙:
【性味】性寒,味甘。归膀胱,小肠经;
【功用】有抗菌、利尿作用,用于上呼吸道感染、流行性腮腺炎、尿路感染等。玉兰花:
【性味】性味辛、温。
【功能主治】具有祛风散寒通窍、宣肺通鼻的功效。可用于头痛、血瘀型痛经、鼻塞、急慢性鼻窦炎、过敏性鼻炎等症。现代药理学研究表明,玉兰花对常见皮肤真菌有抑制作用。其花瓣可供食用,肉质较厚,具特有清香,清代《花镜》谓:“其(花)瓣择洗清洁,拖面麻油煎食极佳,或蜜浸亦可。” 玉兰花含有挥发油,其中主要为柠檬醛、丁香油酸等,还含有木兰花碱、生物碱、望春花素、癸酸、芦丁、油酸、维生素A等成分,具有一定的药用价值。
大青叶:
【性味】气寒,味微苦咸。"
【归经】入肝、心、胃经。
【功用】清热,解毒,凉血,止血。治温病热盛烦渴,流行性感冒,急性传染性肝炎,菌痢,急性胃肠炎,急性肺炎,丹毒,吐血,衄血,黄疸,痢疾,喉痹,口疮,痈疽肿毒。大青叶主要用于热毒发斑、丹毒、咽喉肿痛、口舌生疮、疮痈肿毒等症。
牡丹花:
牡丹不仅有观赏价值,而且还具有很高的药用价值。将牡丹的根加工制成“丹皮”,是名贵的中草药。其性微寒,味辛,无毒,入心、肝、肾三经,有散瘀血、清血、和血、止痛、通经之作用,还有降低血压、抗菌消炎之功效,久服可益身延寿。养血和肝,散郁祛瘀、适用于面部黄褐斑,皮肤衰老,常饮气血活肺,容颜红润,改善月经失调,痛经,止虚汗,盗汗。
乳香:调气,活血,止痛,追毒。抗菌、收敛、祛肠胃胀气、促进伤口结疤、增进细胞活性、利消化、利尿、镇静、补身、利子宫、治创伤。
一枝黄花:
【性味归经】辛、苦,平。入肝、胆二经。
【功用】疏风清热,抗菌消炎。用于风热感冒头痛,(风寒忌)清热解毒,消肿除痛。上呼吸道感染,扁桃体炎,咽喉肿痛,支气管炎,肺炎,肺结核咳血,急、慢性肾炎,小儿疳积,外用治跌打损伤,毒蛇咬伤,疮疡肿毒,乳腺炎,1、抗菌作用:煎剂在体外对金黄色葡萄球菌(多引起化脓炎,皮肤疥痈,小儿支气管炎),绿脓杆菌(肺炎),痢疾(急性菌痢),伤寒杆菌(肠道伤害,忌长期慎用,易出血)、肺炎双球菌(大叶性肺炎),甲型溶血性链球菌(扁桃体炎)及红色藓菌、白色念珠菌(属于真菌引起鹅掌风、灰指甲、脚癣、女性霉菌性阴道炎)均有抑制作用。
淫羊藿:
【味性归经】辛、甘,温。归肝、肾经;
【主治功能】补肾阳,强筋骨,祛风湿。
淫羊藿茎叶含有淫羊藿甙和挥发油。经证实,淫羊藿有雄性激素样的作用,其功效强于蛤蚧和海马。临床显示,它通过促进精液分泌,使精囊充满精液后,反过来又能刺激感觉神经,从而激发性欲而致阴茎勃起。同时,淫羊藿还可以抑制血管运动中枢,扩张周围血管,使血压下降,并能镇咳、祛痰、平喘,对脊髓灰质炎病毒、白色葡萄球菌、金黄色葡萄球菌等也有显著的抑制作用。
淫羊藿在临床上主要用于治疗生殖、骨关节、呼吸系统疾病。淫羊藿配伍熟地、当归、白术、枸杞、杜仲、仙茅、巴戟天、山茱萸、蛇床子、韭菜子、肉苁蓉、制附子、肉桂,称为“赞育丹”,可治阳痿、早泄。淫羊藿配伍威灵仙、苍耳子、川芎,可治关节疼痛。淫羊藿不拘多少,煎汤漱口,可治牙痛。取淫羊藿加矮地茶煎汤服用,可治慢性支气管炎,其祛痰镇咳作用比较明显。取淫羊藿与黄芪、党参、附子、细辛、麻黄等煎煮同用,可治病态窦房结综合征和房室传导阻滞。
但需要提醒的是,有口干、手足心发热、潮热、盗汗等症状,属中医学阴虚相火易动者,则不宜服用淫羊藿。
三棱:
【别名】芩根(《抱朴子》)、京三棱(《开宝本草》)、红蒲根(《本草图经》)、光三棱(《药材资料汇编》)、黑三棱(《救荒本草》)、芩草(《字林》)、三棱草(《千金翼方》)
【性味】味苦,性平。
【功效】破血,行气,消积止痛。
【临床应用】适用于多种肿瘤,如卵巢癌、宫颈癌、肝癌等。常与香附、莪术、紫草根、木馒头等配伍治疗气血结积、瘀血瘀滞的卵巢癌、宫颈癌等。常用白花蛇舌草、大腹皮、茯苓、莪术等配伍治疗气滞血瘀、热毒蕴结的肝癌。此外该品还适用于血瘀气滞、腹部结块、肝脾肿大、经闭腹痛、食积胀痛等。
冰片:
【性味归经】味辛、苦,微寒;归心、脾,肺烃。
【功用】开窍醒神,清热止痛。
薄荷油:
【性味】《中国医学大辞典》:"辛,凉,无毒。"
【功用】芳香药、调味药及驱风药。功用:可用于皮肤或粘膜产生清凉感以减轻不适宜,主疼痛。抗刺激作用导致气管产生新的分泌,而使稠厚的粘液易于排除,故有祛痰、杀菌的作用。
具体实施方式:
实施例1,配方:
人参花20g、金银花20g、回回豆0.1g、芦笋20g、芦荟20g、无花果20g、蜂花粉20g、密陀僧10g、蜈蚣10g、雷公藤10g、千里光10g、没药10g、车前10g、石决明10g、藿香10g、维生素c1g、维生素b1g、结晶磺胺1g、海金沙1g、玉兰花1g、大青叶1g、牡丹花1g、乳香0.1g、一枝黄花0.1g、淫羊藿0.1g、三棱0.1g、冰片5g、薄荷油20g。
制备方法:
①按配方比例将人参花、金银花、玉兰花、牡丹花、蜈蚣烘干粉碎至100-200目细粉备用;
②按配方比例将回回豆、芦笋、芦荟、无花果、密陀僧、雷公藤、千里光、没药、车前、石决明、藿香、海金沙、大青叶、乳香、一枝黄花、淫羊藿、三棱除杂质,去腐败物,加水浸泡30分钟,后加入五倍量的水煎煮1小时,煮提二次煎液,过滤、浓缩滤液至密度1.0-1.45(70-80℃)的膏体,在70℃干燥,粉碎至100-200目细粉备用;
③按配方比例将蜂花粉、维生素c片、维生素b片、结晶磺胺、冰片粉碎至100-200目细粉备用;
④按配方比例将三次备用细粉加入薄荷油搅拌均匀,浇模冷却,制成栓剂。
用法用量:每盒7枚,每枚含200mg。每晚1枚肛门给药,连续使用7天为一完整疗程。
实施例2,配方:
人参花22g、金银花22g、回回豆0.2g、芦笋22g、芦荟22g、无花果22g、蜂花粉22g、密陀僧12g、蜈蚣12g、雷公藤12g、千里光12g、没药12g、车前12g、石决明12g、藿香12g、维生素c2g、维生素b2g、结晶磺胺2g、海金沙2g、玉兰花2g、大青叶2g、牡丹花2g、乳香0.2g、一枝黄花0.2g、淫羊藿0.2g、三棱0.2g、冰片6g、薄荷油22g。
制备方法与实施例1相同。
实施例3,配方:
人参花25g、金银花25g、回回豆0.5g、芦笋25g、芦荟25g、无花果25g、蜂花粉25g、密陀僧15g、蜈蚣15g、雷公藤15g、千里光15g、没药15g、车前15g、石决明15g、藿香15g、维生素c5g、维生素b5g、结晶磺胺5g、海金沙5g、玉兰花5g、大青叶5g、牡丹花5g、乳香0.5g、一枝黄花0.5g、淫羊藿0.5g、三棱0.5g、冰片10g、薄荷油25g。
制备方法与实施例1相同。
实施例4,配方:
人参花28g、金银花28g、回回豆0.8g、芦笋28g、芦荟28g、无花果28g、蜂花粉28g、密陀僧18g、蜈蚣18g、雷公藤18g、千里光18g、没药18g、车前18g、石决明18g、藿香18g、维生素c8g、维生素b8g、结晶磺胺8g、海金沙8g、玉兰花8g、大青叶8g、牡丹花8g、乳香0.8g、一枝黄花0.8g、淫羊藿0.8g、三棱0.8g、冰片14g、薄荷油28g。
制备方法与实施例1相同。
实施例5,配方:
人参花30g、金银花30g、回回豆1.0g、芦笋30g、芦荟30g、无花果30g、蜂花粉30g、密陀僧20g、蜈蚣20g、雷公藤20g、千里光20g、没药20g、车前20g、石决明20g、藿香20g、维生素c10g、维生素b10g、结晶磺胺10g、海金沙10g、玉兰花10g、大青叶10g、牡丹花10g、乳香1.0g、一枝黄花1.0g、淫羊藿1.0g、三棱1.0g、冰片15g、薄荷油30g。
制备方法与实施例1相同。
将本发明复方栓剂进行试验总结如下:
长期毒性试验:
选用SD大鼠,给予不同浓度(18.0、6.0、2.0g生药/kg)的本发明的中药栓剂,每天灌胃一次,连续90天,末次给药后24小时各组活杀1/2动物(雌雄各半),其余1/2动物继续观察2周后活杀。试验期间观察动物的外观、一般行为、摄食量、体重变化,给药后90天和停药2周进行血液学(RBC、HB、网织红细胞、PLT、CT、WBC及分类)和血液生化(AST、ALT、ALP、Glu、BUN、Crea、TP、T.BIL、ALB、CHOL)、尿液生化、脏器系数、病理组织学等指标检查。试验结果表明:本发明制剂在高、中、低剂量组动物一般状态良好,外观体征、行为活动、进食量和体重增长均无异常变化;三个剂量组及对照组血液学检查、血液生化学、尿液生化检查均在正常范围,组间无显著差异;各组主要脏器组织病理学检查未见明显异常。上述指标停药2周后也未见改变。本试验用药剂量分别为临床用药剂量的180、60、20倍,根据试验结果本发明的中药制剂在高、中、低三个剂量(18.0、6.0、2.0g生药/kg)连续90天给药对大鼠无明显影响,无明确的毒性靶器官和敏感指标,恢复期观察也未见延迟性毒性反应,提示本发明的中药制剂临床应用的剂量安全性较高。
急性毒性试验
应用小鼠进行急性毒性实验表明:小鼠口服灌胃本发明的栓剂,在488.8g生药/kg剂量下,给药后小鼠出现轻微活动减少,1小时左右恢复正常,给药后连续观察7天,无一动物死亡,其全身状况、饮食、摄水、小便和体重增长均正常,实验结果表明:小鼠口服灌胃本发明的中药制剂胶囊剂的最大给药量为488.8g生药/kg/d(LD 50 >488.8g生药/kg)。本发明的中药栓剂每日临床用药总量为0.1g生药/kg/d;按体重计,小鼠灌胃本发明的中药制剂的耐受量为临床病人的4888倍。提示该药急性毒性低,临床用药安全。
动物局部刺激试验:
本发明栓剂的豚鼠皮肤过敏试验。结果表明:皮肤过敏试验,高剂量组0.8g(药粉)/kg、低剂量组0.1g(药粉) /kg,分别相当于拟临床人用量[0.04g(药粉)/kg]的20倍、2.5倍,经皮肤给药,均未见动物产生变态反应;直肠用药刺激性试验高剂量组5.0g(药粉) /kg,低剂量组3.2g(药粉)/kg,分别相当于拟临床人用量的125、80倍,在规定的时间内观察直肠粘膜均无充血、水肿等现象,病理组织学检查与空白对照组比较无明显差异,未见出现明显的刺激性反应,每组留存的部分动物其全身状况,体重、呼吸、循环、中枢神经系统及四肢活动等,均无明显异常反应。
临床病人情况:
本发明应用于治疗免疫缺陷患者中进行性的可能威胁生命的感染、抑制细胞中人免疫缺陷病毒的复制,对500名病人在重症特别护理期间进行肛门给药(视情况加减给药),减少了患者因菌感染造成的死亡,有效率显著,为98%以上的患者减轻了痛苦,延长了生命。
Claims (5)
1.一种防治免疫缺陷患者感染的复方栓剂,其特征在于,是由以下重量份的原料组成:
人参花20-30份、金银花20-30份、回回豆0.1-1.0份、芦笋20-30份、芦荟20-30份、无花果20-30份、蜂花粉20-30份、密陀僧10-20份、蜈蚣10-20份、雷公藤10-20份、千里光10-20份、没药10-20份、车前10-20份、石决明10-20份、藿香10-20份、维生素c1-10份、维生素b1-10份、结晶磺胺1-10份、海金沙1-10份、玉兰花1-10份、大青叶1-10份、牡丹花1-10份、乳香0.1-1.0份、一枝黄花0.1-1.0份、淫羊藿0.1-1.0份、三棱0.1-1.0份、冰片5-15份、薄荷油20-30份;
制备方法:
①按配方比例将人参花、金银花、玉兰花、牡丹花、蜈蚣烘干粉碎至100-200目细粉备用;
②按配方比例将回回豆、芦笋、芦荟、无花果、密陀僧、雷公藤、千里光、没药、车前、石决明、藿香、海金沙、大青叶、乳香、一枝黄花、淫羊藿、三棱除杂质,去腐败物,加水浸泡30分钟,后加入五倍量的水煎煮1小时,煮提二次煎液,过滤、浓缩滤液至密度1.0-1.45(70-80℃)的膏体,在70℃干燥,粉碎至100-200目细粉备用;
③按配方比例将蜂花粉、维生素c片、维生素b片、结晶磺胺、冰片粉碎至100-200目细粉备用;
④按配方比例将三次备用细粉加入薄荷油搅拌均匀,浇模冷却,制成栓剂。
2.根据权利要求1所述的一种防治免疫缺陷患者感染的复方栓剂,其特征在于,是由以下重量份的原料组成:
人参花22-28份、金银花22-28份、回回豆0.2-0.8份、芦笋22-28份、芦荟22-28份、无花果22-28份、蜂花粉22-28份、密陀僧12-18份、蜈蚣12-18份、雷公藤12-18份、千里光12-18份、没药12-18份、车前12-18份、石决明12-18份、藿香12-18份、维生素c2-8份、维生素b2-8份、结晶磺胺2-8份、海金沙2-8份、玉兰花2-8份、大青叶2-8份、牡丹花2-8份、乳香0.2-0.8份、一枝黄花0.2-0.8份、淫羊藿0.2-0.8份、三棱0.2-0.8份、冰片6-14份、薄荷油22-28份。
3.根据权利要求1所述的一种防治免疫缺陷患者感染的复方栓剂,其特征在于,是由以下重量份的原料组成:
人参花25份、金银花25份、回回豆0.5份、芦笋25份、芦荟25份、无花果25份、蜂花粉25份、密陀僧15份、蜈蚣15份、雷公藤15份、千里光15份、没药15份、车前15份、石决明15份、藿香15份、维生素c5份、维生素b5份、结晶磺胺5份、海金沙5份、玉兰花5份、大青叶5份、牡丹花5份、乳香0.5份、一枝黄花0.5份、淫羊藿0.5份、三棱0.5份、冰片10份、薄荷油25份。
4.根据权利要求1-3中的任意一项所述的一种防治免疫缺陷患者感染的复方栓剂,其特征在于,维生素c为片剂。
5.根据权利要求1-3中的任意一项所述的一种防治免疫缺陷患者感染的复方栓剂,其特征在于,维生素b为片剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410816003.2A CN104474404A (zh) | 2014-12-25 | 2014-12-25 | 一种防治免疫缺陷患者感染的复方栓剂 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410816003.2A CN104474404A (zh) | 2014-12-25 | 2014-12-25 | 一种防治免疫缺陷患者感染的复方栓剂 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104474404A true CN104474404A (zh) | 2015-04-01 |
Family
ID=52749105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410816003.2A Pending CN104474404A (zh) | 2014-12-25 | 2014-12-25 | 一种防治免疫缺陷患者感染的复方栓剂 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104474404A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106421027A (zh) * | 2016-12-15 | 2017-02-22 | 珠海聚焦先导生物研究院有限公司 | 一种女性私处护理的中药洗液 |
| CN110882278A (zh) * | 2019-12-13 | 2020-03-17 | 浙江佰科堂生物科技股份有限公司 | 五谷虫或其提取物在制备降低肾毒性的药物中的用途 |
| CN112451623A (zh) * | 2020-12-09 | 2021-03-09 | 巧济堂(山东)药业有限公司 | 一种中草药组合物及其制备方法、口服药剂和应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1461646A (zh) * | 2002-05-28 | 2003-12-17 | 周文志 | 一种治疗艾滋病的中药 |
| CN1927259A (zh) * | 2006-08-30 | 2007-03-14 | 深圳市华南动力生物科技有限公司 | 一种防止患者真菌感染的抗真菌药物组合物 |
-
2014
- 2014-12-25 CN CN201410816003.2A patent/CN104474404A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1461646A (zh) * | 2002-05-28 | 2003-12-17 | 周文志 | 一种治疗艾滋病的中药 |
| CN1927259A (zh) * | 2006-08-30 | 2007-03-14 | 深圳市华南动力生物科技有限公司 | 一种防止患者真菌感染的抗真菌药物组合物 |
Non-Patent Citations (1)
| Title |
|---|
| 张信江: "《实用性病手册 》", 31 January 2001, 人民军医出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106421027A (zh) * | 2016-12-15 | 2017-02-22 | 珠海聚焦先导生物研究院有限公司 | 一种女性私处护理的中药洗液 |
| CN110882278A (zh) * | 2019-12-13 | 2020-03-17 | 浙江佰科堂生物科技股份有限公司 | 五谷虫或其提取物在制备降低肾毒性的药物中的用途 |
| CN112451623A (zh) * | 2020-12-09 | 2021-03-09 | 巧济堂(山东)药业有限公司 | 一种中草药组合物及其制备方法、口服药剂和应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103652361A (zh) | 一种产后1-20天哺乳期母猪饲料及其制备方法 | |
| CN103169903B (zh) | 一种治疗小儿支气管炎的中药制剂及其制备方法 | |
| CN104068279B (zh) | 一种含有中药添加剂的鳗鱼饲料及其制备方法 | |
| CN104799115A (zh) | 一种鸡配合饲料及其制备方法 | |
| CN103432475B (zh) | 一种治疗过敏性鼻炎的中药组合物及其制备方法 | |
| CN103719492A (zh) | 一种绞股蓝护肝养肝保健茶及其制备方法 | |
| CN105597071A (zh) | 用于治疗仔猪缺铁性贫血的中药组合物及其制备方法 | |
| CN104208245B (zh) | 手足癣中药药浴及制备方法 | |
| CN103721103B (zh) | 用于治疗猪丹毒的药物及其制备方法 | |
| CN103041256B (zh) | 一种治疗小儿反复呼吸道感染的中药制剂 | |
| CN104474404A (zh) | 一种防治免疫缺陷患者感染的复方栓剂 | |
| CN103041257B (zh) | 治疗小儿发热高烧呼吸道感染的中药制剂 | |
| CN104127702A (zh) | 一种治疗急性视神经炎的中药制剂及其制备方法 | |
| CN103417886B (zh) | 一种治疗支气管哮喘的中药组合物及其制备方法 | |
| CN103007111A (zh) | 一种治疗兔腹泻的中药制剂及其制备方法 | |
| CN103041255B (zh) | 治疗小儿咽喉肿痛呼吸道感染的中药制剂 | |
| CN102846871B (zh) | 一种治疗肝火上炎型眶上神经痛的中药制剂及其制备方法 | |
| CN104988025A (zh) | 保肝护肝药酒 | |
| CN105079451B (zh) | 一种蓝莓降糖茶及其制备方法 | |
| CN103845616A (zh) | 一种消炎杀菌的药物组合物 | |
| CN102940753B (zh) | 一种治疗青光眼的药丸及制备方法 | |
| CN106822660A (zh) | 一种治疗心脑血管疾病的中药制剂 | |
| CN112870275A (zh) | 一种治疗病毒性感冒的中医药组合物及其制备方法 | |
| CN111084878A (zh) | 一种用于肺及呼吸系统疾病的生物医药、医用全营养食品及制备方法 | |
| CN104906502A (zh) | 一种用于治疗鸡伤热的药物组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150401 |
|
| RJ01 | Rejection of invention patent application after publication |